Dr. Ashish Dalal, MD

Hematology Melbourne, FL Male
NPI: 1801857966
Total Payments
$10,660
2024 Payments
$67.25
Companies
64
Transactions
650
Medicare Patients
21,338
Medicare Billing
$10.9M

Payment Breakdown by Category

Food & Beverage$9,299 (87.2%)
Education$1,361 (12.8%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $9,299 622 87.2%
Education $1,361 28 12.8%

Top Paying Companies

Company Total Records Latest Year
Novartis Pharmaceuticals Corporation $1,167 76 $0 (2022)
Amgen Inc. $933.09 41 $0 (2022)
Janssen Biotech, Inc. $814.13 47 $0 (2022)
PFIZER INC. $783.06 64 $0 (2022)
Celgene Corporation $667.00 43 $0 (2022)
Seagen Inc. $615.07 17 $0 (2023)
AstraZeneca Pharmaceuticals LP $596.68 41 $0 (2022)
E.R. Squibb & Sons, L.L.C. $528.45 45 $0 (2022)
Merck Sharp & Dohme LLC $460.16 32 $0 (2024)
Genentech USA, Inc. $401.63 25 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $67.25 3 PharmaEssentia USA Corporation ($32.14)
2023 $133.24 3 Seagen Inc. ($89.00)
2022 $1,355 83 Novartis Pharmaceuticals Corporation ($165.22)
2021 $2,140 115 Seagen Inc. ($217.56)
2020 $1,433 71 Seagen Inc. ($250.20)
2019 $1,962 125 Novartis Pharmaceuticals Corporation ($279.11)
2018 $2,236 156 Novartis Pharmaceuticals Corporation ($547.29)
2017 $1,334 94 Amgen Inc. ($219.61)

All Payment Transactions

650 individual payment records from CMS Open Payments — Page 1 of 26

Date Company Product Nature Form Amount Type
12/07/2024 Merck Sharp & Dohme LLC WELIREG (Drug) Education In-kind items and services $18.09 General
Category: ONCOLOGY
08/22/2024 Regeneron Healthcare Solutions, Inc. LIBTAYO (Biological) Education In-kind items and services $17.02 General
Category: ONCOLOGY
03/19/2024 PharmaEssentia USA Corporation BESREMI (Drug) Food and Beverage In-kind items and services $32.14 General
Category: Oncology
07/07/2023 Foundation Medicine, Inc. FOUNDATIONONE LIQUID CDX Food and Beverage In-kind items and services $23.24 General
03/16/2023 Mirati Therapeutics, Inc. KRAZATI (Drug) Education In-kind items and services $21.00 General
Category: ONCOLOGY
03/09/2023 Seagen Inc. — Education In-kind items and services $89.00 General
07/28/2022 Novartis Pharmaceuticals Corporation — Food and Beverage In-kind items and services $17.47 General
07/27/2022 GENZYME CORPORATION JEVTANA (Drug) Food and Beverage In-kind items and services $19.59 General
Category: Oncology
07/27/2022 AstraZeneca Pharmaceuticals LP — Food and Beverage In-kind items and services $15.59 General
07/26/2022 Celgene Corporation Pomalyst (Drug) Food and Beverage Cash or cash equivalent $20.91 General
Category: Hematology
07/20/2022 Janssen Biotech, Inc. IMBRUVICA (Drug) Food and Beverage In-kind items and services $0.37 General
Category: Oncology
07/18/2022 Janssen Biotech, Inc. IMBRUVICA (Drug) Food and Beverage In-kind items and services $20.33 General
Category: Oncology
07/18/2022 Daiichi Sankyo Inc. ENHERTU (Drug) Food and Beverage In-kind items and services $18.42 General
Category: ONCOLOGY
07/18/2022 Novartis Pharmaceuticals Corporation PROMACTA (Drug) Food and Beverage In-kind items and services $9.19 General
Category: ONCOLOGY
07/14/2022 Novartis Pharmaceuticals Corporation KISQALI (Drug), FEMARA, MEKINIST Food and Beverage In-kind items and services $15.24 General
Category: ONCOLOGY
07/13/2022 Daiichi Sankyo Inc. ENHERTU (Drug) Food and Beverage In-kind items and services $19.52 General
Category: ONCOLOGY
07/12/2022 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $15.29 General
Category: Oncology
07/11/2022 Global Blood Therapeutics, Inc. OXBRYTA (Drug) Food and Beverage In-kind items and services $13.11 General
Category: Sickle Cell Disease
07/06/2022 Bayer HealthCare Pharmaceuticals Inc. Nubeqa (Drug) Food and Beverage In-kind items and services $18.67 General
Category: Oncology
06/30/2022 ABBVIE INC. VENCLEXTA (Drug) Food and Beverage In-kind items and services $21.62 General
Category: ONCOLOGY
06/16/2022 Novartis Pharmaceuticals Corporation SCEMBLIX (Drug), TASIGNA Food and Beverage In-kind items and services $11.84 General
Category: ONCOLOGY
06/09/2022 Lilly USA, LLC CYRAMZA (Drug), VERZENIO, RETEVMO Food and Beverage In-kind items and services $22.84 General
Category: Oncology
06/07/2022 Novartis Pharmaceuticals Corporation KISQALI (Drug), FEMARA Food and Beverage In-kind items and services $17.84 General
Category: ONCOLOGY
06/03/2022 Myovant Sciences Inc. ORGOVYX (Drug) Food and Beverage In-kind items and services $23.09 General
Category: HORMONE THERAPY
06/03/2022 Novartis Pharmaceuticals Corporation KISQALI (Drug), FEMARA Food and Beverage In-kind items and services $6.60 General
Category: ONCOLOGY
123…26»

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 55 3,875 232,779 $8.2M $3.0M
2022 54 3,594 174,910 $6.8M $2.7M
2021 71 6,460 214,716 $6.2M $2.3M
2020 78 7,409 224,112 $7.6M $3.0M
Total Patients
21,338
Total Services
846,517
Medicare Billing
$10.9M
Procedure Codes
258

All Medicare Procedures & Services

258 procedure records from CMS Medicare Utilization — Page 1 of 11

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
J9271 Injection, pembrolizumab, 1 mg Office 2023 28 31,600 $3.3M $1.3M 38.7%
J9299 Injection, nivolumab, 1 mg Office 2023 13 17,060 $1.0M $404,675 39.5%
J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg Office 2023 14 9,560 $859,260 $341,132 39.7%
J0897 Injection, denosumab, 1 mg Office 2023 56 9,660 $436,740 $178,458 40.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 621 1,476 $376,635 $141,217 37.5%
Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units Office 2023 77 11,294 $243,536 $68,255 28.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 624 1,026 $185,124 $64,689 34.9%
J3262 Injection, tocilizumab, 1 mg Office 2023 13 13,680 $159,440 $60,615 38.0%
J9034 Injection, bendamustine hcl (bendeka), 1 mg Office 2023 11 4,526 $199,240 $59,216 29.7%
96413 Administration of chemotherapy into vein, 1 hour or less Office 2023 153 602 $154,121 $57,518 37.3%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 198 355 $127,245 $47,998 37.7%
J1439 Injection, ferric carboxymaltose, 1 mg Office 2023 32 39,750 $118,500 $34,820 29.4%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 208 208 $69,656 $24,658 35.4%
J9217 Leuprolide acetate (for depot suspension), 7.5 mg Office 2023 29 178 $190,220 $23,714 12.5%
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less Office 2023 196 426 $56,856 $20,465 36.0%
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle Office 2023 35 331 $47,231 $18,238 38.6%
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less Office 2023 99 610 $34,668 $13,045 37.6%
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Office 2023 35 26,010 $69,926 $10,389 14.9%
G6015 Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session Office 2023 26 38 $26,296 $9,439 35.9%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 57 57 $25,227 $9,363 37.1%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 78 79 $20,971 $8,091 38.6%
96372 Injection of drug or substance under skin or into muscle Office 2023 212 718 $30,058 $7,474 24.9%
96417 Administration of additional new drug or substance into vein, 1 hour or less Office 2023 36 137 $17,281 $6,693 38.7%
J9025 Injection, azacitidine, 1 mg Office 2023 11 17,070 $54,580 $5,963 10.9%
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l Office 2023 13 41 $12,997 $5,235 40.3%
123…11»

About Dr. Ashish Dalal, MD

Dr. Ashish Dalal, MD is a Hematology healthcare provider based in Melbourne, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801857966.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ashish Dalal, MD has received a total of $10,660 in payments from pharmaceutical and medical device companies, with $67.25 received in 2024. These payments were reported across 650 transactions from 64 companies. The most common payment nature is "Food and Beverage" ($9,299).

As a Medicare-enrolled provider, Dalal has provided services to 21,338 Medicare beneficiaries, totaling 846,517 services with total Medicare billing of $10.9M. Data is available for 4 years (2020–2023), covering 258 distinct procedure/service records.

Practice Information

  • Specialty Hematology
  • Other Specialties Hematology & Oncology, Medical Oncology
  • Location Melbourne, FL
  • Active Since 03/29/2006
  • Last Updated 06/04/2025
  • Taxonomy Code 207RH0000X
  • Entity Type Individual
  • NPI Number 1801857966

Products in Payments

  • IMBRUVICA (Drug) $424.03
  • KEYTRUDA (Biological) $385.66
  • OPDIVO (Biological) $375.14
  • XTANDI (Drug) $336.46
  • KISQALI (Drug) $326.31
  • Abraxane (Drug) $308.81
  • TAGRISSO (Drug) $308.80
  • IBRANCE (Drug) $251.76
  • Nplate (Biological) $218.16
  • PROMACTA (Drug) $217.13
  • JAKAFI (Drug) $190.49
  • TASIGNA (Drug) $179.51
  • LIBTAYO (Biological) $164.51
  • ERLEADA (Drug) $157.06
  • GILOTRIF (Drug) $152.83
  • OCTAGAM IMMUNE GLOBULIN (HUMAN) (Biological) $146.46
  • MEKINIST (Drug) $145.58
  • Avastin (Biological) $136.48
  • Revlimid (Drug) $123.35
  • Enhertu (Drug) $123.29

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Hematology Doctors in Melbourne

Dr. Amit Barochia, Md, MD

Hematology — Payments: $9,390

Hematology $9,390

Joseph Mcclure, Md, MD

Hematology — Payments: $6,188

Hematology $6,188

Dr. Germaine Blaine, Md, MD

Hematology — Payments: $1,452

Hematology $1,452

James Neel, Md, MD

Hematology — Payments: $860.50

Hematology $860.50

Dr. Mustafa Sahin, Md, MD

Hematology — Payments: $802.14

Hematology $802.14

Sean Kearin, Md, MD

Hematology — Payments: $404.03

Hematology $404.03